Letters
Authors' reply on aspirin for primary prevention
BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7279.171 (Published 20 January 2001) Cite this as: BMJ 2001;322:171- T W Meade (t.w.meade@mds.qmw.ac.uk), director,
- P J Brennan, Statistician
- MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, London EC1M 6BQ
EDITOR—By implying disagreements with our study1 which are largely misplaced or non-existent, Ramsay et al may have confused doctors who are deciding about aspirin in the primary prevention of coronary heart disease.2 We pointed out that the British Hypertension Society,3 the hypertension optimal treatment trial,4 and our trial1 all say that aspirin treatment should be started only when blood pressure is satisfactory. Since both aspirin and raised blood pressure are risk factors for …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.